IMCD NV (CHIX:IMCDA) Short-Term Debt: €325 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:IMCDA IMCD NV CHIX:IMCDA
83 GF Score
Price €79.78
GF Value €141.35
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is IMCD NV Short-Term Debt?

IMCD NV CHIX:IMCDA 83 Short-Term Debt is €325 Mil as of Dec. 2025. GuruFocus rates CHIX:IMCDA with a GF Score™ of 83/100 and a GF Value™ of €141.35 (Significantly Undervalued). The stock has 5 warning signs investors should review.

IMCD NV's Short-Term Debt for the quarter that ended in Dec. 2025 was €325 Mil.

IMCD NV's quarterly Short-Term Debt declined from Dec. 2024 (€300 Mil) to Jun. 2025 (€0 Mil) but then increased from Jun. 2025 (€0 Mil) to Dec. 2025 (€325 Mil).

IMCD NV's annual Short-Term Debt increased from Dec. 2023 (€0 Mil) to Dec. 2024 (€300 Mil) and increased from Dec. 2024 (€300 Mil) to Dec. 2025 (€325 Mil).

IMCD NV Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

IMCD NV Short-Term Debt Related Terms

IMCD NV Short-Term Debt Historical Data

* Premium members only.

The historical data trend for IMCD NV's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMCD NV Short-Term Debt Chart

IMCD NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 40.00 0.00 299.87 325.00

IMCD NV Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 299.87 0.00 325.00
CHIX:IMCDA
83GF Score
IMCD NV CHIX:IMCDA
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of €325 Mil mean?
IMCD NV (CHIX:IMCDA) has a Short-Term Debt of €325 Mil as of Dec. 2025.
Is IMCD NV's Short-Term Debt too high?
IMCD NV's current Short-Term Debt is €325 Mil. Overall, IMCD NV has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's Short-Term Debt compare to LIN and SHW?
IMCD NV's Short-Term Debt of €325 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Chemicals company?
A good Short-Term Debt depends on the Chemicals industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. IMCD NV's current Short-Term Debt is €325 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (CHIX:IMCDA) is currently considered Significantly Undervalued. The stock's GF Value™ is €141.35, compared to a current price of €79.78 — trading 43.6% below its estimated fair value. The current Short-Term Debt is €325 Mil. IMCD NV's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For IMCD NV (CHIX:IMCDA), the current Short-Term Debt is €325 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IMCD NV (CHIX:IMCDA) Overvalued in 2026?

Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued. The current stock price of €79.78 is trading 43.6% below its estimated GF Value™ of €141.35. GuruFocus considers IMCD NV to be Significantly Undervalued.

Key valuation signals for CHIX:IMCDA:

  • Short-Term Debt: €325 Mil
  • GF Value™: €141.35 vs. price of €79.78 (43.6% below fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the CHIX:IMCDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMCD NV Business Description

Address Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
83GF Score

Get the complete analysis for CHIX:IMCDA

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€79.78
Price
€141.35
GF Value